BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 1284648)

  • 1. The angiogenesis inhibitor beta-cyclodextrin tetradecasulfate inhibits ecto-protein kinase activity.
    Skubitz KM; Ehresmann DD
    Cell Mol Biol; 1992 Sep; 38(6):543-60. PubMed ID: 1284648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of human neutrophil ecto-protein kinase activity released by kinase substrates.
    Skubitz KM; Ehresmann DD; Ducker TP
    J Immunol; 1991 Jul; 147(2):638-50. PubMed ID: 1712814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of human vascular smooth muscle cell migration and proliferation by beta-cyclodextrin tetradecasulfate.
    Okada SS; Kuo A; Muttreja MR; Hozakowska E; Weisz PB; Barnathan ES
    J Pharmacol Exp Ther; 1995 May; 273(2):948-54. PubMed ID: 7752099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Separate and combined effects of local and continuous intravenous administration of beta-cyclodextrin tetradecasulfate on intimal hyperplasia after angioplasty in porcine coronary arteries.
    Meneveau NF; Klugherz BD; Chaquor B; Golden MA; Jouille MM; Macarek E; Weisz PB; Wilensky RL
    J Cardiovasc Pharmacol Ther; 2003 Mar; 8(1):53-60. PubMed ID: 12652330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of microvascular endothelial cell migration by beta-cyclodextrin tetradecasulfate and hydrocortisone.
    Stokes CL; Weisz PB; Williams SK; Lauffenburger DA
    Microvasc Res; 1990 Sep; 40(2):279-84. PubMed ID: 1701207
    [No Abstract]   [Full Text] [Related]  

  • 6. Angiostatic steroids potentiated by sulfated cyclodextrins inhibit corneal neovascularization.
    Li WW; Casey R; Gonzalez EM; Folkman J
    Invest Ophthalmol Vis Sci; 1991 Oct; 32(11):2898-905. PubMed ID: 1917393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon gamma bound to endothelial cells is phosphorylated by ecto-protein kinases.
    Al-Nedawi KN; Pawłowska Z; Cierniewski CS
    Acta Biochim Pol; 1999; 46(3):693-702. PubMed ID: 10698277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. beta-cyclodextrin tetradecasulfate/tetrahydrocortisol +/- minocycline as modulators of cancer therapies in vitro and in vivo against primary and metastatic Lewis lung carcinoma.
    Teicher BA; Sotomayor EA; Huang ZD; Ara G; Holden S; Khandekar V; Chen YN
    Cancer Chemother Pharmacol; 1993; 33(3):229-38. PubMed ID: 8269604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Affinity of fibroblast growth factors for beta-cyclodextrin tetradecasulfate.
    Yuen SN; Folkman J; Weisz PB; Joullie MM; Ewing WR
    Anal Biochem; 1990 Feb; 185(1):108-11. PubMed ID: 2344037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of human fibroblast activity by selected angiogenesis inhibitors.
    Wong J; Wang N; Miller JW; Schuman JS
    Exp Eye Res; 1994 Apr; 58(4):439-51. PubMed ID: 7523160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basic fibroblast growth factor is a substrate for phosphorylation by human neutrophil ecto-protein kinase activity.
    Skubitz KM; Goueli SA
    Biochem Biophys Res Commun; 1991 Jan; 174(1):49-55. PubMed ID: 1989619
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of angiostatic steroids and beta-cyclodextrin tetradecasulfate on corneal neovascularization in the rat.
    Proia AD; Hirakata A; McInnes JS; Scroggs MW; Parikh I
    Exp Eye Res; 1993 Dec; 57(6):693-8. PubMed ID: 7512045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for CKI and CKII at the cell surface.
    Walter J; Kinzel V; Kübler D
    Cell Mol Biol Res; 1994; 40(5-6):473-80. PubMed ID: 7735321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of angiogenesis with synthetic heparin substitutes.
    Folkman J; Weisz PB; Joullié MM; Li WW; Ewing WR
    Science; 1989 Mar; 243(4897):1490-3. PubMed ID: 2467380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 18 kDa isoform of basic fibroblast growth factor is sufficient to stimulate human melanoma growth and angiogenesis.
    Fontijn D; Duyndam MC; Beliën JA; Gallegoz Ruiz MI; Pinedo HM; Boven E
    Melanoma Res; 2007 Jun; 17(3):155-68. PubMed ID: 17505261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ecto-protein kinase activity on the external surface of neural cells.
    Ehrlich YH; Davis TB; Bock E; Kornecki E; Lenox RH
    Nature; 1986 Mar 6-12; 320(6057):67-70. PubMed ID: 3005875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiangiogenic agents potentiate cytotoxic cancer therapies against primary and metastatic disease.
    Teicher BA; Sotomayor EA; Huang ZD
    Cancer Res; 1992 Dec; 52(23):6702-4. PubMed ID: 1384969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ecto- and exo-protein kinases in Schistosoma mansoni: regulation of surface phosphorylation by acetylcholine and identification of the alpha subunit of CKII as a major secreted protein kinase.
    Tarrab-Hazdai R; Hanoch T; Jeon SH; Pauli H; Gold D; Arnon R; Seger R
    J Parasitol; 2005 Aug; 91(4):756-63. PubMed ID: 17089740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shedding of tyrosine and serine/threonine ecto-protein kinases from human leukemic cells.
    Paas Y; Fishelson Z
    Arch Biochem Biophys; 1995 Feb; 316(2):780-8. PubMed ID: 7864634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membrane lipid microdomains differentially regulate intracellular signaling events in human neutrophils.
    Tuluc F; Meshki J; Kunapuli SP
    Int Immunopharmacol; 2003 Dec; 3(13-14):1775-90. PubMed ID: 14636828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.